phase 2 clinical trial

phase 2 clinical trial

Phase 2 study. See Phase study.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
M2 EQUITYBITES-August 12, 2019-PolyPid admits 200 patients under its Phase 2 clinical trial of D-PLEX100 in abdominal surgery
Global Banking News-August 12, 2019-PolyPid admits 200 patients under its Phase 2 clinical trial of D-PLEX100 in abdominal surgery
M2 PHARMA-August 12, 2019-PolyPid admits 200 patients under its Phase 2 clinical trial of D-PLEX100 in abdominal surgery
Our IND for a Phase 2 clinical trial in cystic fibrosis is open in the U.S.
The FDA approved a Phase 2 clinical trial using an allogeneic mesenchymal stem cell-based drug, the first in Taiwan and in Asia to obtain the second Phase of U.S.
announced last July that the FDA had raised no objections to the company's Investigational New Drag (IND) application for a Phase 2 clinical trial in polyglutamine spinocerebellar ataxia (PolyQ SCA) conducted at clinical sites in the U.S.
Neuren Pharmaceuticals, Sydney, Australia, has announced the detailed pharmacokinetics analysis of the Phase 2 clinical trial of its lead compound, Glypromate(R), for the reduction of cognitive decline following cardiac surgery.
Data presented at the 2003 annual meeting of the American Society of Clinical Oncology (ASCO) from the Phase 2 clinical trial of XL119 showed that patients with bile duct tumors (gall bladder tumors and cholangiocarcinomas) treated with XL119 showed encouraging results relative to overall survival and progression free survival (alive without progressive disease, i.e., patients with partial response or stable disease).
M2 EQUITYBITES-January 26, 2016-Cellceutix doses 75% of subjects under Phase 2 clinical trial of Prurisol for chronic plaque psoriasis
SAN FRANCISCO, Calif, December 23, 2013 -- A stem cell therapy aimed at treating patients who have had a heart attack has been given approval to begin a Phase 2 clinical trial.
OncoGenex Technologies Inc., Vancouver, has initiated a Phase 2 clinical trial of OGX-011 in newly diagnosed, previously untreated patients with clinically localized, high-risk prostate carcinoma.